Aug 19, 01:28 AM

FDA Warns of Semaglutide Scams and Health Risks

New research indicates that many online platforms selling the weight loss drug semaglutide without a prescription are scams, potentially distributing toxic liquids that do not contain the labeled amount of the drug. The Food and Drug Administration (FDA) has issued warnings about the dangers of using compounded semaglutide products, as reports have surfaced of symptoms associated with overdosing. Semaglutide, marketed under brand names such as Wegovy and Ozempic, can cause severe or prolonged gastrointestinal issues if dosing errors occur, necessitating medical attention.

#Food and Drug Administration #FDA #Wegovy #Ozempic

Written with ChatGPT (GPT-4o).

Sources

Scientific American@sciam
2 years ago
Dosing errors in the medication semaglutide, prescribed as Wegovy and Ozempic, can cause severe or prolonged gastrointestinal issues that require medical attention https://t.co/eB7qaIx7rY
Health@health_com_
2 years ago
The Food and Drug Administration is warning people of the dangers of using compounded semaglutide products after people have reported symptoms associated with overdosing. https://t.co/F31mxdp2nA
Daily Mail Online@MailOnline
2 years ago
The little-known side effects of Ozempic, Wegovy and Mounjaro no one talks about. Here's the price you really have to pay… https://t.co/lTb8FjfvuV https://t.co/P8dmlx9Osf

Additional media

Image #1 for story fda-warns-semaglutide-scams-health-risks

Image #2 for story fda-warns-semaglutide-scams-health-risks

FDA Warns of Semaglutide Scams and Health Risks

Sources

Additional media

Similar Stories